Physician profile
Frank R Johnston
NPI 1568825016
$19,155.56
in general payments reported to CMS, 2019-2025
32 companies · $2,796 in 2025
The $2,796 reported for 2025 was more than what 76% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,955 · 2020: $240 · 2021: $851 · 2022: $6,077 · 2023: $4,915 · 2024: $2,321 · 2025: $2,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,185 · Grant: $3,000 · Travel and Lodging: $1,847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,184.73 |
| Grant | $3,000.00 |
| Travel and Lodging | $1,847.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,182.43 | 2022-2025 | Endurant Iis, In.Pact Admiral |
| W. L. Gore & Associates, INC. | $4,940.77 | 2022-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Penumbra, INC. | $2,103.41 | 2023-2025 | Indigo System, Smart Coil |
| Intuitive Surgical, INC. | $1,467.41 | 2019 | |
| Bolton Medical INC | $769.25 | 2023-2024 | Treo Abdominal Stent-Graft System |
| Allergan, INC. | $319.32 | 2019-2022 | |
| Medical Device Business Services, INC. | $305.00 | 2021 | |
| Endologix LLC | $285.89 | 2022 | |
| Stryker Corporation | $269.55 | 2019-2025 | Flowtriever, Artix Mt |
| Ethicon US, LLC | $215.28 | 2019-2025 | Vistaseal |
| Kci USA, INC. | $190.47 | 2019-2022 | |
| Biom'Up Sa | $140.37 | 2019 | |
| Pfizer INC. | $138.58 | 2019-2022 | |
| Csl Behring | $137.96 | 2019-2021 | |
| Cardiva Medical, INC. | $125.02 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $100.03 | 2024-2025 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Janssen Pharmaceuticals, INC | $65.14 | 2021-2022 | |
| Mimedx Group, INC. | $52.49 | 2025 | |
| Smith+Nephew, INC. | $46.42 | 2024-2025 | Stravix, Grafix Pl |
| Pacira Pharmaceuticals Incorporated | $44.30 | 2020-2022 | |
| Terumo Medical Corporation | $42.77 | 2024 | Azur Cx Detachable |
| Ossur Americas, INC. | $29.77 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $24.65 | 2019 | |
| Baylis Medical Technologies INC. | $22.75 | 2024 | |
| Baudax Bio INC. | $21.04 | 2022 | |
| Kerecis Limited | $19.03 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Merck Sharp & Dohme LLC | $17.97 | 2021 | |
| Cook Medical LLC | $17.75 | 2020 | |
| Integra Lifesciences Corporation | $17.50 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $16.01 | 2020 | |
| Angiodynamics, INC. | $13.84 | 2025 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $13.39 | 2024 | Jeti All In One Non-Sterile Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.